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Several studies have found sucrose to be superior to water in neonates for reducing pain associated with needle stick procedures (eg, heel lancing, venipuncture, subcutaneous injection). [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] Sucrose solutions of higher concentrations (24%) were found to be better than lower concentrations (12%) at reducing pain associated with painful procedures. 10 The vast majority of these studies evaluated the effectiveness of sucrose to blunt the pain associated with heel sticks, 8, [12] [13] [14] [16] [17] [18] [19] [20] [21] 23 with venipuncture evaluated in several studies, 10, 11, 19, 21, 22 and subcutaneous injections in another. 15 Despite the frequency of arterial punctures in neonates, no studies were found that evaluated the effectiveness of sucrose to decrease pain during or after that type of needlestick puncture.
The purpose of this study was to determine the effect of oral sucrose solution on pain responses of neonates to arterial puncture compared with neonates who did not receive a sucrose solution.
MATERIALS AND METHODS
This study was conducted in a 40 bed, level III, NICU of a 564 bed community-based hospital in the Midwest region of the United States. Study approval was obtained from the institution's investigational review board prior to data collection.
Study Design
A double-blind, randomized controlled trial (RCT) study design was used to compare different methods for decreasing pain associated with an arterial puncture: oral sucrose solution administration; no sucrose solution with comfort measures. The primary outcome variable was the change in pain scores during and after the arterial puncture compared to baseline values. Secondary outcome variables were heart rate and oxygen saturation levels. Random assignment to groups was done using a computer randomization scheme.
• Sample Selection. This study used a convenience sample of premature infants admitted to the NICU. Inclusion criteria were the following: 30 to 36 weeks' gestation, 48 hours of age, nothingby-mouth status, and medical requirement for an arterial puncture. Exclusion criteria included intubation, narcotic analgesia administered since admission, and/or fetal exposure to maternal opioids. A minimum sample size of 39 subjects was determined a priori with power analysis for chi-square tests, using a calculated effect size of 0.5 based on data from prior studies, 11, 21 power of 0.8, and P Ͻ .05. 24, 25 • Instruments. Pain was measured with the Neonatal Infant Pain Scale (NIPS). 26 Neonates behavioral response to pain are assessed and rated with 6 subscales: facial expression, cry, breathing patterns, arm position, leg position, and state of arousal (Table 1) . Accompanying each of the subscale categories are operational definitions for each behavioral disruption. Scores for behaviors in each subscale range from 0 for behaviors associated with no pain (eg, relaxed face; no crying) to 1 for behaviors that are often seen with pain (eg, facial grimace, flexed/extended arms or legs). The crying subscale has 3 levels, with scores from 0 to 2 (Table 1 ). Neonate behavior is assessed in each of the subscales, scored, and then totaled. Maximum total scores range from 0 to 7, with higher scores representing behaviors consistent with infant pain. Validity and reliability of the NIPS instrument in infants 32 to 36 weeks' gestational age has previously been determined (Cronbach ␣ ϭ 0.88-0.95; Pearson r ϭ 0.92-0.97). 26 • Heart rate was recorded from the digital display on the bedside cardiac monitor (IntelliVue MP50PN M8004A, Medezin System, Philips Medical, Boeblingen, Germany) connected to cardiac electrodes attached to the infant's chest according to manufacturer's directions. 
Study Procedure
Prior to data collection, investigators were trained in the use of all instruments used in the study.
Investigators were all registered nurses with more than 2 years of experience as staff nurses in the NICU, which included extensive use of the NIPS pain assessment scale, heart rate monitor, and O 2 saturation monitor. Interrater reliability testing was not formally determined prior to data collection. All patients who met the eligibility criteria for the study had demographic data recorded. Immediately prior to the therapeutically ordered arterial puncture, the study investigator removed themselves from the infant's room while the nurse caring for the infant opened a sealed envelope with the randomization assignment to treatment groups. Infants assigned to the sucrose solution treatment group were then orally given a 0.5 mL solution of oral sucrose (Sweet-Ease, preservative-free, 24% sucrose solution 99044, Children's Medical Ventures, Norwell, Massachusetts) in a 1-mL syringe by the nurse caring for the infant. Infants assigned to the placebo group did not receive any oral solution.
The investigator was then called back to the infant's bedside, remaining blinded to treatment group assignment. The investigator then obtained baseline study data (NIPS; heart rate; SpO 2 ). Each infant was given a pacifier, which was lightly held in place and the infant's extremities swaddled by the nurse assigned to care for the infant. An arterial puncture was then performed by another nurse (not the study investigator). The study investigator obtained study data (NIPS, heart rate, SpO 2 ) immediately after the arterial puncture needle was inserted and again 1 minute after the arterial puncture procedure was completed.
For infants assigned to the sucrose treatment group, the time from sucrose administration to when the arterial puncture occurred was at least 1 minute but not more than 3 minutes. Group assignment codes were not revealed to study investigators until study enrollment was completed.
Data Analysis
An intent-to-treat analysis (inclusion of all subject enrolled in study) was used in this study. Data were summarized using descriptive statistics. Prior to data analysis, change scores were calculated for all pain scores by subtracting the baseline NIPS value before the arterial puncture from the NIPS value immediately after the skin was punctured with the needle and again at 1 minute after completion of the arterial puncture. Data were analyzed with chi-square analysis (NIPS change scores) and analysis of variance and a Bonferroni multiple comparison test (heart rate, SO 2 ) to test for differences between the sucrose and no sucrose groups on the primary (NIPS scores) and secondary (heart rate, oxygen saturation) outcome variables of the study. The level of significance for all tests was P Ͻ .05.
RESULTS
A total of 49 infants were enrolled in the study over a 12-month period, but only data for 47 subjects were included for data analysis (2 subjects had no baseline, during, or after needlestick data collection due to nonstudy-related logistical problems). Subjects ranged in gestational age from 31 to 35 weeks, with an average gestational age of 33.8 (SD ϭ Ϯ1.1) weeks. No differences were found in the ages for the sucrose and no sucrose groups (33.7 Ϯ 1.0 and 33.9 Ϯ 1.1 weeks, respectively). None of the arterial punctures required a second needlestick to successfully obtain an arterial blood sample.
Primary Outcome
Neonatal Infant Pain Scale scores before the beginning of the arterial puncture were low (Figure) , ranging from 0 to 3 for the total NIPS (scale range 0 to 7), with the majority of subjects (87%) having a total score of 0. Chi-square analyses of the change in NIPS subscale and total scores found significantly lower subscale scores for changes in crying in the sucrose group than the no sucrose group at the time of the needle puncture, as well as 1 minute after completion of the arterial puncture procedures ( 2 ϭ 9.30, df ϭ 2, p ϭ 0.006; 2 ϭ 7.62, df ϭ 2, P ϭ 0.022, respectively) ( Table 2 ). None of the other NIPS subscale or NIPS total scores were found to be significantly different between the 2 groups (all P values Ͼ .05).
Secondary Outcomes
Changes in heart rate and oxygen saturation (SpO 2 ) from baseline values were similar for both groups immediately after needle insertion and 1 minute after completion of the arterial puncture ( Table 2) . Analysis of variance found no statistical differences for heart rates or oxygen saturation levels between the sucrose and no sucrose groups (P Ͼ .05). No adverse events occurred and no anecdotal findings were recorded during the study.
DISCUSSION
This study found that neonates receiving a 24% oral sucrose solution before an arterial puncture had significantly lower scores on the crying subscale of the NIPS than neonates who did not receive sucrose solution. While a number of previous studies in neonates have evaluated sucrose to blunt the pain responses associated with other needlestick procedures (heel stick, 8, [12] [13] [14] [16] [17] [18] [19] [20] [21] 23 venipunctures, 10, 11, 19, 21, 22 and/or subcutaneous injections 15 ), ours is the first to evaluate sucrose with arterial punctures. Similar to our study, the majority of the other studies found that oral administration of sucrose (24% to 50% solutions) was effective in blunting pain associated with the needlestick. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] Similar responses to oral sucrose have also been found in studies of term infants. 3 In the only study which compared different concentrations of sucrose solutions in neonates, 10 12% sucrose was not found to be effective in reducing pain, whereas the 24% sucrose solution was effective.
None of the other subscales of the NIPS (facial expression, breathing pattern, arm and leg movement, arousal) were found to differ between the 2 groups. Lack of change in the arm and leg subscales of the NIPS was not surprising because infants' arms and legs were immobilized in the swaddling done by the nurse during and immediately after the arterial puncture, obscuring any observation of limb movement. Lack of change in other subscales, though, may have been due to the limited number of levels in these subscales (only 2) compared to the crying subscale which has 3 levels or that the pacifier use and swaddling provided some measure of comfort and pain relief. Another possibility is that the pain associated with arterial punctures is of a low intensity and/or duration. When the NIPS was tested for validity and reliability, Lawrence et al observed that pain levels associated with different types of needle stick procedures were not similar, with arterial puncture having the lowest pain level compared with venous and capillary punctures, which had NIPS scores 2 or more times larger than arterial punctures. 26 While the differences in pain scores between the 3 types of needle punctures were not shown to be statistically significant, the authors hypothesized that the lack of significance was likely due to the analysis being underpowered (N ϭ 9 for arterial; N ϭ 14 for venous; and N ϭ 6 for capillary punctures). Post hoc power analysis demonstrated that each procedure group should have had at least 25 subjects to show differences based on standard power analysis assumptions.
Another finding in our study was that heart rate and oxygen saturation levels were similar for the 2 groups. Both physiologic variables were stable throughout the study period. The majority of other RCT of oral sucrose to diminish pain with needle stick procedures also evaluated these variables, with none of the studies finding significant changes in oxygen saturation [10] [11] [12] 17, [20] [21] [22] and only one finding a significant difference in heart rate. 22 The limited duration and severity of the pain associated with needle stick procedures may account for this lack of difference, despite significant increases in crying after the needle stick procedure.
Because this is the first study to evaluate oral sucrose administration for pain associated with arterial punctures, future research should replicate this study in neonates. In addition, future research should also determine the ability of high concentrations of oral sucrose administration to blunt the pain responses in neonates less than 31 weeks' gestation.
LIMITATIONS OF THE STUDY
This study only evaluated one concentration of sucrose solution. One previous study in neonates of 12% versus 24% sucrose did not find the 12% solution effective in blunting the pain response, whereas the 24% solution was effective. 10 It is possible that concentrations less than 24%, but higher than 12%, may be effective as well in blunting the pain response. Because repetitive administration of high levels of sucrose solutions could cause elevations in serum glucose levels, finding the lowest dose of sucrose that could blunt the pain response would be beneficial. In addition, multiple scorers of the NIPS were used which could affect the study findings. While all the NIPS assessments were performed by investigators trained in the use of the behavioral pain scale, poor interrater reliability could account for a lack of significance in some of the NIPS subscales. A small study of Italian nurses found only moderate interrater agreement with the NIPS. 27 Interrater reliability should be done in subsequent studies. Determination of the severity of illness and further description of the sample (ie, birth weight) may have strengthened the study findings.
CLINICAL IMPLICATIONS
The findings of this study extend the findings of previous studies on the ability of high concentration of oral sucrose to blunt the pain responses associated with heel stick, venipuncture, and subcutaneous injections to the pain associated with arterial puncture. Administration of high concentrations of oral sucrose should be considered as one approach to pain management during arterial punctures.
CONCLUSIONS
This study found a significant reduction in the crying NIPS subscale immediately after the introduction of an arterial needle in neonates receiving a 24% sucrose solution, compared with those receiving no sucrose solution. No differences were found in heart rate or oxygen saturation values between the 2 groups.
